logo
Share SHARE
FONT-SIZE Plus   Neg

European Commission Gives Green Light To Bayer HealthCare's Flexyess

Bayer AG (BYR.L,BAYRY.PK,BAYZF.PK) said the European Commission has issued its go ahead for the approval of the company's subgroup Bayer HealthCare's new low-dose combined oral contraceptive Flexyess. Based on the European Commission's positive decision, the Health Authorities of the EU Member States will grant national approvals in the coming weeks.

Flexyess will be the first low-dose combined oral contraceptive approved in the EU member states for a flexible extended regimen, offering women the option of 'personal period planning', meaning they can choose both the number and timing of their periods according to their needs.

Dr. Flemming Ornskov, chief marketing officer at Bayer HealthCare's Pharmaceuticals division, said, "Once Flexyess is launched, women will have the convenience and flexibility to influence the timing of their periods according to their individual needs."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Toy maker Mattel, Inc. (MAT), has announced it will not extend its licensing deal with SeaWorld Entertainment Inc. (SEAS), and end the production of all SeaWorld-related merchandise including SeaWorld Trainer Barbie dolls. "We're not making the dolls anymore," a Mattel spokesman said to the New York... Ride-sharing service Uber Technologies Inc. is facing a lawsuit filed by the National Federation of the Blind of California alleging discrimination of blind people. According to the lawsuit, Uber drivers' discriminate blind persons by refusing to transport their guide dogs along with them. The lawsuit... Video game publisher Activision Blizzard has officially unveiled Call of Duty: Black Ops III, after some teases and a trailer as well. The game will be shipped starting November 6, and will be available on Xbox One, PS4, and PC.
comments powered by Disqus
Follow RTT